Document Detail


A comparative study of clarithromycin and penicillin VK in the treatment of outpatients with streptococcal pharyngitis.
MedLine Citation:
PMID:  1827105     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This double-blind, randomized 17-centre clinical trial compared the safety and efficacy of clarithromycin (2 x 125 mg capsules) 12-hourly and penicillin VK (2 x 125 mg tablets in capsules) 6-hourly in the treatment of proven Group A, beta-haemolytic streptococcal pharyngitis. One hundred and twenty-eight patients (clarithromycin: 65, penicillin VK: 63) were enrolled in the study and included in the safety analysis. Clinical and bacteriological evaluations were performed on treatment days 5-7, and within two to ten and 15 to 56 days post-treatment. The post-treatment clinical success and bacteriological cure rates for clarithromycin were 95% (41/43) and 88% (38/43), respectively, with both rates 91% (43/47) for penicillin VK. Three clarithromycin patients withdrew because of adverse events, but only one of these events was possibly drug related. More clarithromycin patients (19/65) reported digestive system related adverse events than did penicillin VK patients (8/63); however, there was no significant difference between treatment groups in the overall number of patients reporting adverse events. Clarithromycin (250 mg, 12-hourly) is a safe and effective as penicillin VK (250 mg, 6-hourly) in the treatment of streptococcal pharyngitis.
Authors:
R T Bachand
Related Documents :
2226485 - The design of clinical trials with antibiotics.
10223595 - Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the trea...
16760445 - Single-dose azithromycin for the treatment of cholera in adults.
2572475 - Oral versus local treatment of vaginal candidosis.
17604055 - Distinguishing psychogenic and essential tremor.
17999075 - Assessment of psychopathological aspects and psychiatric comorbidities in patients affe...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  The Journal of antimicrobial chemotherapy     Volume:  27 Suppl A     ISSN:  0305-7453     ISO Abbreviation:  J. Antimicrob. Chemother.     Publication Date:  1991 Feb 
Date Detail:
Created Date:  1991-06-04     Completed Date:  1991-06-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7513617     Medline TA:  J Antimicrob Chemother     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  75-82     Citation Subset:  IM    
Affiliation:
Abbott International Ltd, Abbott Park, Illinois 60064-3500.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Ambulatory Care
Child
Clarithromycin
Double-Blind Method
Erythromycin / administration & dosage,  adverse effects,  analogs & derivatives*,  therapeutic use
Female
Humans
Male
Middle Aged
Penicillin V / administration & dosage,  adverse effects,  therapeutic use*
Pharyngitis / drug therapy*
Streptococcal Infections / drug therapy*
Streptococcus pyogenes*
Chemical
Reg. No./Substance:
114-07-8/Erythromycin; 81103-11-9/Clarithromycin; 87-08-1/Penicillin V

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clarithromycin versus penicillin in the treatment of streptococcal pharyngitis.
Next Document:  The comparative efficacy and safety of clarithromycin and amoxycillin in the treatment of outpatient...